Published Paper Details:

The prevalence of skin diseases, particularly skin cancer, presents a global health challenge an increasing impact on the economy and workforce. Melanoma, arising from dysfunctional melanocytes, is the most aggressive form of skin cancer, in constrast non-melanoma skin cancers (NMSC) like squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) account for the majority of cases. The incidence of NMSC has risen significantly, with men being at higher risk due to genetic, phenotypic, and environmental factors. Advances in polymeric micro/nano carrier-based therapies offer promising avenues for skin cancer management, including drug and gene delivery, and combination therapies. These innovative approaches hold the potential for overcoming current treatment limitations and advancing both research and clinical applications in the field. Nisosomes can be important nanomolecules For the cancer management and drug delivery. In this review, we are discussing the nisosomes as a nanocarrirer for drug delivery in skin cancer.